Literature DB >> 16380853

Acute medical problems due to Ecstasy use. Case-series of emergency department visits.

Matthias E Liechti1, Isabelle Kunz, Hugo Kupferschmidt.   

Abstract

STUDY AIM: To describe the clinical characteristics of Ecstasy (3,4-Methylenedioxymethamphetamine, MDMA) toxicity.
METHODS: Retrospective case-study of 52 self-reported Ecstasy intoxications presenting to our Emergency Department (ED) between January 2001 and December 2003.
RESULTS: Most patients ingested Ecstasy together with other substances, including alcohol (51.9%) or other illicit drugs (71.1%). Medical problems leading to ED presentation were collapse or loss of consciousness (36.5%), palpitations (19.2%), dizziness or weakness (15.4%), and anxiety (13.5%). When other drugs were used in combination with Ecstasy the clinical presentation significantly changed. Panic reactions were observed in 4 of 13 patients with cocaine co-use (30.7%), compared to 3 of 39 patients without cocaine use (7.7%). Deep coma was found in 11 of 16 patients with co-use of gamma-hydroxybutyrate (GHB) or opiates (68.8%) but in none of the 36 patients who took Ecstasy without these drugs. Most patients were monitored in the ED. Six patients (11.5%) were transferred to an intensive care unit. Medical complications were severe in five patients and included cardiac arrest, hyperthermia, rhabdomyolysis, disseminated intravascular coagulation, renal insufficiency and liver failure, seizures, and one fatal outcome.
CONCLUSIONS: The clinical picture of Ecstasy related problems is complicated by multiple drug ingestion. Co-use of cocaine induces panic reactions. Co-use of GHB or opiates results in depressed levels of consciousness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380853     DOI: 2005/43/smw-11231

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  26 in total

1.  Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

Authors:  Cm Hysek; Y Schmid; A Rickli; L D Simmler; M Donzelli; E Grouzmann; M E Liechti
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Ecstasy-induced myocardial infarction in a teenager: rare complication of a widely used illicit drug.

Authors:  Michael Möller; Jens Völz; Robert Paliege; Corinna Lenz; Rainer Gradaus; Jörg Neuzner
Journal:  Clin Res Cardiol       Date:  2010-09-07       Impact factor: 5.460

3.  Acute myelopathy selectively involving lumbar anterior horns following intranasal insufflation of ecstasy and heroin.

Authors:  N Riva; P Morana; F Cerri; S Gerevini; S Amadio; F Formaglio; G Comi; M Comola; U Del Carro
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08       Impact factor: 10.154

4.  Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation.

Authors:  Cédric M Hysek; Yasmin Schmid; Anna Rickli; Matthias E Liechti
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

5.  Acute myelopathy selectively involving lumbar anterior horns following intranasal insufflation of ecstasy and heroin.

Authors:  Nilo Riva; Nilo Riva; Paolo Morana; Federica Cerri; Simonetta Gerevini; Stefano Amadio; Fabio Formaglio; Giancarlo Comi; Mauro Comola; Ubaldo Del Carro
Journal:  BMJ Case Rep       Date:  2009-01-23

6.  Disinhibiting neurons in the dorsomedial hypothalamus delays the onset of exertional fatigue and exhaustion in rats exercising in a warm environment.

Authors:  Dmitry V Zaretsky; Hannah Kline; Maria V Zaretskaia; Mary Beth Brown; Pamela J Durant; Nathan J Alves; Daniel E Rusyniak
Journal:  Brain Res       Date:  2018-03-22       Impact factor: 3.252

7.  Sexual risk behavior associated with co-administration of methamphetamine and other drugs in a sample of HIV-positive men who have sex with men.

Authors:  Shirley J Semple; Steffanie A Strathdee; Jim Zians; Thomas L Patterson
Journal:  Am J Addict       Date:  2009 Jan-Feb

8.  Microinjection of muscimol into the dorsomedial hypothalamus suppresses MDMA-evoked sympathetic and behavioral responses.

Authors:  Daniel E Rusyniak; Maria V Zaretskaia; Dmitry V Zaretsky; Joseph A DiMicco
Journal:  Brain Res       Date:  2008-06-14       Impact factor: 3.252

9.  Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.

Authors:  Nisha Vijay; Marilyn E Morris
Journal:  J Pharm Sci       Date:  2014-08-29       Impact factor: 3.534

10.  Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Katherine M Keyes; Silvia S Martins; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2008-06-03       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.